WASHINGTON, D.C. — The New York Times today published an op-ed by David Mitchell, cancer patient and founder of Patients For Affordable Drugs, breaking down how the COVID-19 vaccine story makes it clearer than ever why Americans need our government to negotiate prices for all prescription drugs – including vaccines. Mitchell’s piece is in response to experts’ predictions that we will continue to need COVID-19 vaccines for years to come and vaccine makers’ warnings that they will raise vaccine prices in the future.
Click here to read the full article. |